NewsTin - Science http://www.newstin.com/us/science Global Social News Platform Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. Stickleback fish may teach us lessons in adaptation http://www.newstin.com/tag/us/57513520 By Lynda V. Mapes Seattle Times staff reporter It's got a Dr. Seuss name and a prehistoric appearance, but the threespine stickleback of Lake Washington is opening new frontiers of scientific understanding about how animals adapt to rapid environmental change. While evolution is usually expected... Fri, 16 May 2008 06:57:24 GMT http://www.newstin.com/tag/us/57513520 2008-05-16T06:57:24Z ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts http://www.newstin.com/tag/us/57487509 Posted on: Friday, 16 May 2008, 00:00 CDT ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced that results from Interleukin 21 (IL-21) studies will be presented or published at the American Society of Clinical Oncology (ASCO) 2008 annual meeting. Renal cell cancer is the lead indication for IL-21,... Fri, 16 May 2008 05:00:05 GMT http://www.newstin.com/tag/us/57487509 2008-05-16T05:00:05Z NASA / Northrop Agreement Opens Door to Science Investigations http://www.newstin.com/tag/us/57466945 To: TECHNOLOGY EDITORS Contact: Beth Hagenauer of NASA Dryden Flight Research Center, +1- 661-276-7960, beth.hagenauer@nasa.gov; or Gemma Loochkartt of Northrop Grumman Corporation, +1-858-618-4245, gemma.loochkartt@ngc.com EDWARDS, Calif., May 15 /PRNewswire-USNewswire/ -- NASAs Dryden Flight... Thu, 15 May 2008 23:00:06 GMT http://www.newstin.com/tag/us/57466945 2008-05-15T23:00:06Z Eisai's Commitment to Oncology Demonstrated By Clinical Data to Be Presented at ASCO Annual Meeting http://www.newstin.com/tag/us/57487434 WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ -- Eisai Corporation of North America announced today that results from 16 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th... Fri, 16 May 2008 05:00:05 GMT http://www.newstin.com/tag/us/57487434 2008-05-16T05:00:05Z CORRECTING and REPLACING Notice of the Annual Meeting of Stockholders of EpiCept Corporation http://www.newstin.com/tag/us/57466384 News source: Business Wire Second sentence, first graf under Item Three should begin: The Board approved the submission... (sted On DATE NEEDED, 2008, the board approved the submission...). The corrected release reads: NOTICE OF THE ANNUAL MEETING OF STOCKHOLDERS OF EPICEPT CORPORATION Regulatory... Fri, 16 May 2008 01:19:47 GMT http://www.newstin.com/tag/us/57466384 2008-05-16T01:19:47Z CerviLenz Receives JumpStart Investment http://www.newstin.com/tag/us/57466763 CLEVELAND, May 15 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the growth of innovative early-stage businesses and ideas, has announced an investment commitment of $350,000 in CerviLenz(TM), Inc. Thu, 15 May 2008 23:00:37 GMT http://www.newstin.com/tag/us/57466763 2008-05-15T23:00:37Z Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American... http://www.newstin.com/tag/us/57482184 Posted on: Thursday, 15 May 2008, 21:00 CDT SOUTH SAN FRANCISCO, Calif., May 15 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that the Company will present data from three clinical trials of picoplatin, in various tumor... Fri, 16 May 2008 02:00:06 GMT http://www.newstin.com/tag/us/57482184 2008-05-16T02:00:06Z Thomson Reuters Expands Japanese Patent Coverage in Derwent World Patents Index http://www.newstin.com/tag/us/57482793 Attention Business And Technology Editors Addition of English-translated Japanese Utility Models Provides Most Comprehensive Access to Proliferating Asian Patent Data PHILADELPHIA, May 16 /CNW/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and... Fri, 16 May 2008 00:04:33 GMT http://www.newstin.com/tag/us/57482793 2008-05-16T00:04:33Z Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study http://www.newstin.com/tag/us/57493891 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study - Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that Nexavar(R) (sorafenib) tablets significantly improved overall survival by 47.3 percent... Fri, 16 May 2008 06:30:00 GMT http://www.newstin.com/tag/us/57493891 2008-05-16T06:30:00Z ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety Profile of Its Oral... http://www.newstin.com/tag/us/57487481 Posted on: Friday, 16 May 2008, 00:00 CDT ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced results of an open-label, Phase 1 multi-center, dose-ranging study of oral deforolimus, showing consistency with results observed in previous studies of intravenous deforolimus. These data... Fri, 16 May 2008 05:00:05 GMT http://www.newstin.com/tag/us/57487481 2008-05-16T05:00:05Z